Bacterial capsular polysaccharide and sugar transferases

Capsular polysaccharides (CPs) of several pathogenic bacteria are thought to be good materials for the development of new therapeutic reagents. These polysaccharides can be used as vaccines against infection of pathogenic bacteria and are also useful as inhibitors for disease caused by aberrant and abnormal cell-cell interaction, such as cancer metastasis and inflammation. Since bacterial Cps are diverse in structure and these bacteria have a variety of sugar transferases responsible for the synthesis of Cps, bacterial CP synthesis (cps) genes have attracted much interest as a source of glycosyltransferases useful for glyco engineering. In this review, we describe physiological effects of the bacterial CPs on mammalian cells, and the structure and function of the cps genes, by focusing on group B streptococci, Streptococcus agalactiae type Ia and Ib, that produce high-molecular weight polysaccharides consisting of the following pentasaccharide repeating units: -44)-[alpha-D-NeupNAc-(2 ->)-beta-D-Galp-(1 -> 4)-beta-D-GlcpNAc-(1 -> 3)]-beta-D-Galp-(1 -> 4)-beta-D-Glcp-(1 -> and -> 4)-[alpha-D-NeupNAc-(2 -> 3)-beta-D-Galp-(1 -> 3)-beta-D-GlcpNAc-(1 -> 3)]-beta-D-Galp-(1 -> 4)-beta-D-Glcp-(1 ->, respectively.